Back to Search
JAMES AMATRUDA, MD PHD
MD PHD
Pediatric Hematology & Oncology Physician
NPI: 1689643140Individual
Specialties, Licenses & Credentials
Pediatric Infectious Diseases Physician
Pediatrics — Pediatric Infectious Diseases
Code: 2080P0208X
M2245(TX)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
M2245(TX)
Research & Publications (20)
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.
PMID 19410457·Bioorg Med Chem Lett·2009
7-preclinical
Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus.
PMID 19253204·Horm Metab Res·2009
3-trial
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.
PMID 19232032·Curr Med Res Opin·2009
4-observational
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
PMID 19125156·Nat Chem Biol·2009
8-other
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea.
PMID 19097665·Diabetes Res Clin Pract·2009
2-rct
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis.
PMID 18954434·BMC Endocr Disord·2008
8-other
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency.
PMID 18518892·Diabetes Obes Metab·2008
4-observational
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.
PMID 18510930·Cell·2008
7-preclinical
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes.
PMID 18194595·Curr Med Res Opin·2008
4-observational
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
PMID 18177726·Cell Metab·2008
2-rct
The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.
PMID 17895999·PLoS One·2007
7-preclinical
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
PMID 17712121·Obesity (Silver Spring)·2007
4-observational
Indanylacetic acids as PPAR-delta activator insulin sensitizers.
PMID 17601734·Bioorg Med Chem Lett·2007
8-other
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
PMID 17426325·Obesity (Silver Spring)·2007
4-observational
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults.
PMID 17341568·J Clin Endocrinol Metab·2007
4-observational
A mutation in separase causes genome instability and increased susceptibility to epithelial cancer.
PMID 17210788·Genes Dev·2007
7-preclinical
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.
PMID 17011500·Cell Metab·2006
4-observational
Small molecules that delay S phase suppress a zebrafish bmyb mutant.
PMID 16372403·Nat Chem Biol·2005
4-observational
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility.
PMID 16150706·Proc Natl Acad Sci U S A·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1935 MEDICAL DISTRICT DR
DALLAS, TX 75235 - Phone
- (214) 456-7000
Quick Facts
- NPI
- 1689643140
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile